Summary
- Revenue
- APLS current annual revenue is $1.00B, up +28.46% year-over-year
- Next Earnings
- As of today, the next earnings release for APLS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Apellis Pharmaceuticals, Inc. |
| Ticker | NASDAQ: APLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | apellis.com |
| Employees | 705 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $1.00B | ||
| Revenue, 1Y Change | +28.46% | |
| $0.17 | ||
| EPS, 1Y Change | +110.80% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.17 | ||
| EPS Estimate | -$1.17 | N/A |
| EPS Est. Change | -780.86% | N/A |
| $1.00B | ||
| Revenue Estimate | $924.86M | N/A |
| Revenue Est. Change | -7.86% | N/A |
| Current Price | - | |
| Price Target | $41.00 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.71 | -$1.60 | +6.88% | |
| $0.26 | $0.17 | -33.18% | |
| -$1.17 | N/A | -780.86% | |
| -$0.31 | N/A | -282.31% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $766.26M | $781.37M | +1.97% | |
| $1.00B | $1.00B | -0.09% | |
| $924.86M | N/A | -7.86% | |
| $1.03B | N/A | +2.44% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.00B | ||
| $0.17 | ||
| $901.55M | ||
| 89.81% | ||
| $55.43M | ||
| 5.52% | ||
| $22.39M | ||
| 2.23% | ||
| $56.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 1.28 | ||
| 3.14 | ||
| 2.70 | ||
| - | ||
| 6 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $370.15M | ||
| $467.76M | ||
| $1.08B | ||
| $1.01B | ||
| $705.11M | ||
| $323.60M | ||
| $474.36M | ||
| $100.75M | ||
| $56.80M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $981.39M | ||
| $846.12M | ||
| $102.24M | ||
| $0.00 | ||
| $1.56M | ||
| $0.00 | ||
| $1.72M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $45.33M | ||
| -$313.00K | ||
| $8.88M | ||
| $313.00K | ||
| $45.01M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| William Blair | ||
| Scotiabank | ||
| Wells Fargo | → | |
| Baird | → | |
| Needham | → | |
| Mizuho | → | |
| JP Morgan | → | |
| JP Morgan | → | |
| Wedbush | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
No data
Screeners with APLS
FAQ
- What is the ticker symbol for Apellis Pharmaceuticals, Inc.?
- The ticker symbol for Apellis Pharmaceuticals, Inc. is NASDAQ:APLS
- Does Apellis Pharmaceuticals, Inc. pay dividends?
- No, Apellis Pharmaceuticals, Inc. does not pay dividends
- What sector is Apellis Pharmaceuticals, Inc. in?
- Apellis Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Apellis Pharmaceuticals, Inc. in?
- Apellis Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Apellis Pharmaceuticals, Inc. based in?
- Apellis Pharmaceuticals, Inc. is headquartered in United States
- When did Apellis Pharmaceuticals, Inc. go public?
- Apellis Pharmaceuticals, Inc. initial public offering (IPO) was on November 9, 2017
- Is Apellis Pharmaceuticals, Inc. in the S&P 500?
- No, Apellis Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Apellis Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Apellis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Apellis Pharmaceuticals, Inc. in the Dow Jones?
- No, Apellis Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Apellis Pharmaceuticals, Inc. last earnings report?
- Apellis Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
- When does Apellis Pharmaceuticals, Inc. report earnings?
- The date for Apellis Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- APLS Official Website apellis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1492422/000119312526065179/0001193125-26-065179-index.htm
- APLS Profile on Yahoo Finance finance.yahoo.com/quote/APLS
- APLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apls
